Clinical Trial Update: Metformin Use in Cardiac Fibrosis in PAI-1 Deficiency [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating metformin for cardiac fibrosis in plasminogen activator inhibitor-1 deficiency is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Fibrosis
• Plasminogen Activator Inhibitor-1 Deficiency

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Indiana Hemophilia &Thrombosis Center, Inc. | Conditions: Plasminogen Activator Inhibitor-1 Deficiency, Cardiac Fibrosis | Phase 4 | Status: ACTIVE_NOT_RECRUITING